American Well Corporation (AMWL)
NYSE NYSE Primary 
American Well Corporation (AMWL) Q3 2025 Earnings Call Transcript
American Well Corporation ( AMWL ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ido Schoenberg - Chairman & CEO Mark Hirschhorn - Executive VP, COO & CFO Conference Call Participants Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Charles Rhyee - TD Cowen, Research Division Jenny Cao - Truist Securities, Inc., Research Division Jack Senft - UBS Investment Bank, Research Division John Park - Morgan Stanley, Research Division Presentation Operator " Ido Schoenberg Chairman & CEO " Mark Hirschhorn Executive VP, COO & CFO " Stanislav Berenshteyn Wells Fargo Securities, LLC, Research Division " Wells Fargo Securities, LLC, Research Division Charles Rhyee TD Cowen, Research Division " TD Cowen, Research Division Jenny Cao Truist Securities, Inc., Research Division " Truist Securities, Inc., Research Division Jack Senft UBS Investment Bank, Research Division " UBS Investment Bank, Research Division John Park Morgan Stanley, Research Division " Morgan Stanley, Research Division Operator Hello, everyone, and welcome to Amwell's conference call to discuss their third fiscal quarter of 2025. Joining us on the call today are Amwell's Chairman and CEO, Dr. Ido Schoenberg; and Mark Hirschhorn, Amwell's CFO and Chief Operating Officer.
Compared to Estimates, American Well (AMWL) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
From Apps to Nutrition: Health & Fitness Stocks to Buy Now
UNFI, AMWL, STKL, and PTON stand out as health and fitness plays, tapping into booming demand for wellness, nutrition and digital care.
American Well Q2 Review: Hold Rating Maintained Amid DHA Renewal Concerns
American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to higher-margin software revenue is promising, but guidance was revised downward due to contract uncertainties and program exclusions. Cost reductions have improved EBITDA and cash flow outlook, but excessive cuts risk undermining R&D, marketing, and future growth potential.
American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) Q2 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Ido Schoenberg - Chairman & CEO Mark J. Hirschhorn - Executive VP, COO & CFO Sue Dooley - Head of Investor Relations Conference Call Participants Eric R.
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.84. This compares to a loss of $3.36 per share a year ago.
American Well (AMWL) Soars 5.0%: Is Further Upside Left in the Stock?
American Well (AMWL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Well (AMWL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?
HIMS targets personalized, AI-powered care with bold obesity moves, while AMWL bets on system-wide integration via Converge and top-tier health alliances. Who wins? Let's see.
All You Need to Know About American Well (AMWL) Rating Upgrade to Buy
American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect?
The consensus price target hints at a 46.5% upside potential for American Well (AMWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
